Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed DrugsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72024-12-050OAAI
Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic DevelopmentsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72023-12-203OAAI
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro ActivityCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52023-08-1110OAAI
A decision process for drug discovery in retinoblastomaINVESTIGATIONAL NEW DRUGSIF2.72020-11-1612OAAI